The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
SC Heslinga,1,2 TC Konings,3 IE van der Horst-Bruinsma,1,2 O Kamp,3 VP van Halm,3,4 HACM de Bruin-Bon,4 MJ Peters,5 MT Nurmohamed1,2 1Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands; 2Department of Rheumatology, Amsterdam Rheumatology and I...
Guardado en:
Autores principales: | Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Kamp O, van Halm VP, de Bruin-Bon HACM, Peters MJ, Nurmohamed MT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/988fb7197f174491abd1036633527c76 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Prevalence of Cardiac Diseases in a Contemporary Large Cohort of Dutch Elderly Ankylosing Spondylitis Patients—The CARDAS Study
por: Milad Baniaamam, et al.
Publicado: (2021) -
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis
por: Rossella Talotta, et al.
Publicado: (2020) -
Relationship between periodontal status and disease activity in patients with ankylosing spondylitis
por: Ayşe Ünal Enginar, et al.
Publicado: (2021) -
Trabecular Bone Score (TBS) in Patients with Early Ankylosing Spondylitis—Limited Utility
por: Anna Nowakowska-Płaza, et al.
Publicado: (2021) -
Advances in nanomedicine for the treatment of ankylosing spondylitis
por: Xi Y, et al.
Publicado: (2019)